$0.128
-0.084 (-65.40%)At close
BLMZ News
BLMZ Events
Harrison Global finalizes equity investment in CoinBridge
Harrison Global Holdings announced the completion of a strategic equity investment into CoinBridge. CoinBridge is building the on-chain gateway linking global capital to premium real-world assets, providing seamless fiat on/off ramp via stablecoins and access to yield-driven RWAs. It also advises on tokenization for asset originators to close the loop between off-chain value and on-chain liquidity, leading the next wave of blockchain finance. The investment was executed through Harrison Global's wholly-owned subsidiary, Asia-Pacific Stablecoin Digital Asset Trading Group. Under the agreement - now fully signed and finalized - the Purchaser acquired 5% of CoinBridge's issued shares from an existing shareholder for a total purchase price of $2,500,000, consisting of $1,000,000 in cash and $1,500,000 in Bitcoin
Harrison Global Partners with White Lion Capital for Bitcoin Agreement
Harrison Global entered a binding term sheet with White Lion Capital to establish a Bitcoin Purchase Agreement, representing a key milestone in the company's strategic expansion into the digital asset space. This agreement also signals the launch of Harrison Global's Bitcoin Treasury Strategy, a forward-looking approach to integrating Bitcoin as a core component of its balance sheet. The proposed Bitcoin acquisition reflects Harrison Global's recognition of digital assets as a resilient and appreciating store of value, especially considering growing global institutional adoption. Through this initiative, the company aims to diversify its treasury reserves, protect against inflationary pressures, and position itself for the evolving future of decentralized finance. Final approval will be required from Harrison Global's Board of Directors and is contingent upon compliance with all applicable securities regulations.
Harrison Global Introduces Korean and Japanese Media Content to Europe and South America
This initiative aims to expand opportunities for Korean cultural content, including web novels, animation, music, dramas, movies, food, beauty, and fashion, to reach a global audience. Harrison Global Holdings, which has invested in several companies in the cultural content sector in Japan and Korea, announced that it is preparing to establish a 10 billion yen fund dedicated to cultural content in collaboration with European investors. The fund will focus on localizing and commercializing Korean and Japanese content across the European market, with a particular emphasis on developing content platforms and tailoring content for European audiences. Geographically, the fund will target European and South American language markets. The fund will jointly develop and operate localization projects targeting European and South American fandoms, including promoting IP sales, remaking content, and launching various content platforms for web novels, dramas, and music. They are also discussing the establishment of a joint venture to support the development of a long-term content business platform.
Harrison Global Showcases Strategic Advancements During Market Fluctuations
Harrison Global Holdings issued a strategic business update in light of recent developments and short-term stock activity. BLMZ shares closed at $0.166 in the latest trading session, reflecting short-term market fluctuations amid broader industry dynamics. The company remains focused on executing its strategic roadmap, which is aimed at creating long-term shareholder value. Harrison Global continues to expand its footprint in high-growth sectors through a series of targeted acquisitions and partnerships: Acquisition of Myth Korea: Expected to accelerate Harrison Global's expansion in Asia and unlock new revenue opportunities in the entertainment sector, leveraging South Korea's global pop culture influence. Acquisition of Pokemon Center Korea: This acquisition represents a significant milestone in Harrison Global's commitment to immersive consumer entertainment. Pokemon Center Korea, a licensed brand hub for one of the world's most beloved franchises, adds high-margin merchandise, retail foot traffic, and global brand equity to Harrison's entertainment portfolio. Partnership with Biotree; A move to diversify the company's portfolio and unlock long-term growth potential within the health sector, tapping into advanced biotech and wellness innovations. Collaboration with GRAPES: Designed to strengthen Harrison's leadership in AI-driven digital entertainment and virtual artist markets, reflecting the company's focus on next-generation media platforms. "Our recent acquisitions and partnerships are not just aligned with our vision - they are measurable steps toward it," said a spokesperson for Harrison Global Holdings Inc. "By 2026, we aim to integrate these initiatives into a unified digital entertainment and health-tech ecosystem, delivering sustainable growth and maximizing shareholder value."
Harrison Global signs international business partnership agreement with Biotree
Harrison Global Holdings signed a strategic international business partnership agreement with Biotree. Biotree has completed Phase 1 clinical trials in the United States for PH-100, its natural product-based treatment targeting metabolic syndrome and diabetic complications. Additionally, Biotree has concluded Phase 2A clinical trials across 12 university hospitals in Korea. The Phase 2A clinical trial results confirmed a significant reduction in inflammatory markers and showed positive effects on cardiovascular disease without adverse side effects. Pending the successful completion of the ongoing Phase 2B clinical trials, the drug is expected to be conditionally approved and launch as a prescription-only treatment in the first half of 2026. Among seaweeds, Gamtae stands out for its notable health benefits, including dementia prevention, vascular health support, and anticancer effects - often called the ocean's natural nutrient. Biotree is the first Korean company to extract "Seapolynol," a marine polyphenol, from Gamtae, and has since developed and sold a diverse range of products spanning health functional foods, pharmaceuticals, daily necessities, and cosmetics. Biotree has quietly expanded its presence in both domestic and international markets.Harrison Global Holdings plans to actively pursue the global expansion of Biotree's new drug technology and raw materials for metabolic syndrome treatments, including exports to markets such as the US, Japan, China, and Asia. Under the partnership, the scope of operations includes, but is not limited to: Establishing a joint venture or licensing agreement for operations in local countries Joint development of new natural product drugs and their localization in each country Sharing of branding, distribution channels, and technological infrastructure Cooperation in introducing and developing local partners Regulatory compliance, media strategy, and local PR support.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.